Anamorelin clinical trials
Also written RC-1291 HCl.
A product of RC-1291; its studies count on that page too.
How each study uses anamorelin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 5
Helsinn Therapeutics (U.S.), Inc (6) · M.D. Anderson Cancer Center (2) · Helsinn Healthcare SA (2) · Tufts University (1) · Lahey Clinic (1) · VA Office of Research and Development (1)
Related medicines
As reviewed, each with the page that says it.
- A brand or code of RC-1291
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test anamorelin, phase 3 first.
- Dec 2026Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung CancerPhase 2/3 · M.D. Anderson Cancer Center
Studies
Open first, then newest update. How each study uses anamorelin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid TumorsActive, not recruitingPhase 2M.D. Anderson Cancer CenterNCT03035409Written as Anamorelin HydrochlorideHow we know
- Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung CancerActive, not recruitingPhase 2/3M.D. Anderson Cancer CenterNCT03637816Written as Anamorelin HydrochlorideHow we know
- A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 2CompletedPhase 3Helsinn Healthcare SANCT03743064Written as anamorelin HClHow we know
- A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 1CompletedPhase 3Helsinn Healthcare SANCT03743051Written as Anamorelin HydrochlorideHow we know
- Anamorelin Study for Advanced Pancreatic CancerTerminatedPhase 2Lahey ClinicNCT04844970Written as Anamorelin HydrochlorideHow we know
- Effect of a Ghrelin Receptor Agonist on Muscle and BoneCompletedPhase 1Tufts UniversityNCT04021706Written as Anamorelin HydrochlorideHow we know
- The Role of Ghrelin in Cancer CachexiaTerminatedPhase 2VA Office of Research and DevelopmentNCT01505764Written as Anamorelin HClHow we know
- Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)CompletedPhase 3Helsinn Therapeutics (U.S.), IncNCT01387282Written as Anamorelin HClHow we know
- Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)CompletedPhase 3Helsinn Therapeutics (U.S.), IncNCT01387269Written as Anamorelin HClHow we know
- Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)CompletedPhase 3Helsinn Therapeutics (U.S.), IncNCT01395914Written as Anamorelin HClHow we know
- Dose Range Study of Anamorelin in Patients With Non-small Cell Lung CancerCompletedPhase 2Helsinn Therapeutics (U.S.), IncNCT00622193Written as anamorelin HClHow we know
- Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.CompletedPhase 2Helsinn Therapeutics (U.S.), IncNCT00267358Written as RC-1291 HClHow we know
- Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight LossCompletedPhase 2Helsinn Therapeutics (U.S.), IncNCT00219817Written as RC-1291 HClHow we know
Codes
What other systems call anamorelin · ClinicalTrials.gg INT000140
- MeSH (NLM) C000593861anamorelinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) DD5RBA1NKFANAMORELINConfirmed NLM, Wikidata
- Wikidata Q20707542anamorelinConfirmed NLM, Wikidata
- NCI Thesaurus C52197AnamorelinOne source FDA
- DrugBank DB06645One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000593861 | anamorelin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | DD5RBA1NKF | ANAMORELIN | Confirmed NLM, Wikidata |
| Wikidata | Q20707542 | anamorelin | Confirmed NLM, Wikidata |
| NCI Thesaurus | C52197 | Anamorelin | One source FDA |
| DrugBank | DB06645 | — | One source Wikidata |
Also registered as anamorelin hydrochloride (UNII 55F75LJQ0V).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.